Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New Chk1 kinase inhibitors under study at Abbott

Nov. 3, 2004

New phenylsulfonamide-based gamma-secretase inhibitors and their use in AD

Nov. 3, 2004

New factor Xa inhibitors in early development at Boehringer Ingelheim

Nov. 3, 2004

New CD80 antagonists and their use claimed by Avidex

Nov. 3, 2004

New vitamin D analogues and their use in bone diseases, cancer, etc.

Nov. 3, 2004

Novel Src kinase inhibitors covered by AstraZeneca patent

Nov. 3, 2004

New atherosclerosis vaccine developed by GSK team

Nov. 3, 2004

Novel CDK2/CDK5 inhibitors claimed by IRM researchers

Nov. 2, 2004

AstraZeneca scientists design novel gamma-secretase inhibitors

Nov. 2, 2004

Novel Chk1 inhibitors and their use covered by AstraZeneca patent

Nov. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...